These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6779643)

  • 21. Disodium valproate: new preparation. An alternative for acute mania after lithium failure or intolerance.
    Prescrire Int; 2001 Aug; 10(54):113-5. PubMed ID: 11718180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Valproate for bipolar disorder.
    Med Lett Drugs Ther; 1994 Aug; 36(929):74-5. PubMed ID: 8047048
    [No Abstract]   [Full Text] [Related]  

  • 23. Valproate in psychiatric disorders: literature review and clinical guidelines.
    McElroy SL; Keck PE; Pope HG; Hudson JI
    J Clin Psychiatry; 1989 Mar; 50 Suppl():23-9. PubMed ID: 2494155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Linear relationship of valproate serum concentration to response and optimal serum levels for acute mania.
    Allen MH; Hirschfeld RM; Wozniak PJ; Baker JD; Bowden CL
    Am J Psychiatry; 2006 Feb; 163(2):272-5. PubMed ID: 16449481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Valproic acid amide in the treatment of affective and schizoaffective disorders.
    Puzyński S; Kłosiewicz L
    J Affect Disord; 1984 Feb; 6(1):115-21. PubMed ID: 6142911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Divalproex in the treatment of bipolar disorder.
    Keck PE; McElroy SL
    Psychopharmacol Bull; 2003; 37 Suppl 2():67-73. PubMed ID: 15021862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium.
    Scheffer RE; Kowatch RA; Carmody T; Rush AJ
    Am J Psychiatry; 2005 Jan; 162(1):58-64. PubMed ID: 15625202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.
    Vieta E; Owen R; Baudelet C; McQuade RD; Sanchez R; Marcus RN
    Curr Med Res Opin; 2010 Jun; 26(6):1485-96. PubMed ID: 20429835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lithium excretion and therapeutic response in mania.
    Sampath G; Channabasavanna SM; Rao BS; Subhash MN
    Indian J Med Res; 1981 May; 73():768-71. PubMed ID: 7262950
    [No Abstract]   [Full Text] [Related]  

  • 30. Valnoctamide as a valproate substitute with low teratogenic potential in mania: a double-blind, controlled, add-on clinical trial.
    Bersudsky Y; Applebaum J; Gaiduk Y; Sharony L; Mishory A; Podberezsky A; Agam G; Belmaker RH
    Bipolar Disord; 2010 Jun; 12(4):376-82. PubMed ID: 20636634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety.
    Sachs GS; Grossman F; Ghaemi SN; Okamoto A; Bowden CL
    Am J Psychiatry; 2002 Jul; 159(7):1146-54. PubMed ID: 12091192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effect of number of previous episodes of affective disorder on response to lithium or divalproex in acute mania.
    Swann AC; Bowden CL; Calabrese JR; Dilsaver SC; Morris DD
    Am J Psychiatry; 1999 Aug; 156(8):1264-6. PubMed ID: 10450271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Valproate in bipolar disorder: 2000 onwards.
    Bowden CL; Singh V
    Acta Psychiatr Scand Suppl; 2005; (426):13-20. PubMed ID: 15833096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double-blind comparative clinical trial of pimozide and chlorpromazine in mania. A test of the dopamine hypothesis.
    Cookson J; Silverstone T; Wells B
    Acta Psychiatr Scand; 1981 Nov; 64(5):381-97. PubMed ID: 7051755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A study of naloxone with schizophrenic and manic patients.
    Sethi BB; Prakash R
    Br J Psychiatry; 1981 Jun; 138():501-3. PubMed ID: 7028200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Valproate treatment of alcohol withdrawal and mania.
    Hammer BA; Brady KT
    Am J Psychiatry; 1996 Sep; 153(9):1232. PubMed ID: 8780434
    [No Abstract]   [Full Text] [Related]  

  • 37. Does valproic acid warrant therapeutic drug monitoring in bipolar affective disorder?
    Haymond J; Ensom MH
    Ther Drug Monit; 2010 Feb; 32(1):19-29. PubMed ID: 19901867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A mood stabilizer with risperidone or haloperidol for mania.
    Andrade C
    Am J Psychiatry; 2004 Nov; 161(11):2140. PubMed ID: 15514435
    [No Abstract]   [Full Text] [Related]  

  • 39. Older patients are eligible for trial of lithium and valproate.
    Rendell JM; Geddes JR; Ostacher MJ
    BMJ; 2003 Aug; 327(7411):395-6. PubMed ID: 12920009
    [No Abstract]   [Full Text] [Related]  

  • 40. Neurologic factors predict a favorable valproate response in bipolar and schizoaffective disorders.
    Stoll AL; Banov M; Kolbrener M; Mayer PV; Tohen M; Strakowski SM; Castillo J; Suppes T; Cohen BM
    J Clin Psychopharmacol; 1994 Oct; 14(5):311-3. PubMed ID: 7806685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.